- Home
- ODC vs ORIC Comparison
ODC vs ORIC Comparison
Compare ODC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODC
- ORIC
- Stock Information
- Founded
- ODC 1941
- ORIC 2014
- Country
- ODC United States
- ORIC United States
- Employees
- ODC N/A
- ORIC N/A
- Industry
- ODC Miscellaneous manufacturing industries
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- ODC Consumer Discretionary
- ORIC Health Care
- Exchange
- ODC Nasdaq
- ORIC Nasdaq
- Market Cap
- ODC 316.2M
- ORIC 362.9M
- IPO Year
- ODC N/A
- ORIC 2020
- Fundamental
- Price
- ODC $50.17
- ORIC $8.17
- Analyst Decision
- ODC
- ORIC Strong Buy
- Analyst Count
- ODC 0
- ORIC 8
- Target Price
- ODC N/A
- ORIC $18.83
- AVG Volume (30 Days)
- ODC 31.5K
- ORIC 1.6M
- Earning Date
- ODC 06-05-2025
- ORIC 05-05-2025
- Dividend Yield
- ODC 1.24%
- ORIC N/A
- EPS Growth
- ODC 18.90
- ORIC N/A
- EPS
- ODC 3.13
- ORIC N/A
- Revenue
- ODC $465,340,000.00
- ORIC N/A
- Revenue This Year
- ODC N/A
- ORIC N/A
- Revenue Next Year
- ODC N/A
- ORIC N/A
- P/E Ratio
- ODC $16.02
- ORIC N/A
- Revenue Growth
- ODC 8.24
- ORIC N/A
- 52 Week Low
- ODC $29.47
- ORIC $3.90
- 52 Week High
- ODC $50.50
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- ODC 76.09
- ORIC 72.38
- Support Level
- ODC $47.25
- ORIC $5.52
- Resistance Level
- ODC $48.82
- ORIC $8.44
- Average True Range (ATR)
- ODC 0.98
- ORIC 0.63
- MACD
- ODC 0.25
- ORIC 0.32
- Stochastic Oscillator
- ODC 92.77
- ORIC 93.11
About ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.